Christopher Lyons, MD
Adult Reconstructive Orthopaedic Surgery · Exton, PANPI 1093718017
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in PA, where the typical reported total is $4,565.
Across 54 payments — averaging $26.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$218
- Pacira Therapeutics, Inc.$190
- Smith+Nephew$116
- Dynasplint Systems Inc.$112
- Zimmer Biomet$104
- Amniox Medical, Inc.$97
- plus $612 from 14 others
What the payments were for
- Food & beverage$1,448100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 5 | $218 |
| Pacira Therapeutics, Inc. | 11 | $190 |
| Smith+Nephew | 5 | $116 |
| Dynasplint Systems Inc. | 2 | $112 |
| Zimmer Biomet | 2 | $104 |
| Amniox Medical, Inc. | 1 | $97 |
| Eclipse Technology Solutions Inc. | 2 | $83 |
| Johnson & Johnson | 5 | $82 |
| Endo Pharmaceuticals Inc. | 5 | $71 |
| Ferring Pharmaceuticals Inc. | 3 | $63 |
| Vertex | 3 | $52 |
| Solventum Corporation | 2 | $39 |
| Bioventus LLC | 1 | $37 |
| Heraeus Medical, LLC. | 1 | $36 |
| Pacira Pharmaceuticals Incorporated | 1 | $33 |
| KCI USA, Inc. | 1 | $33 |
| Mallinckrodt Enterprises LLC | 1 | $29 |
| Integra Lifesciences Corporation | 1 | $23 |
| Davol Inc. | 1 | $20 |
| Axogen | 1 | $13 |
How this compares
$1,448 in reported general payments places this provider in the 30th percentile of 51 adult reconstructive orthopaedic surgery providers in Pennsylvania.
See all adult reconstructive orthopaedic surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 17 | $209 |
| Meloxicam | 60 | $151 |
| Oxycodone Hcl | 36 | $103 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Exton
- Robert BoothPhiladelphia$15M
- Javad ParviziPhiladelphia$2.8M
- Thomas MeadeBethlehem$411K
- Kevin AnbariAllentown$344K
- Christopher MelnicPhiladelphia$307K
- Frank Johannes PlatePittsburgh$239K
- Gary UpdegroveHershey$119K
- Jonathon BrownAllentown$89K
- Jeffrey SeweckePittsburgh$84K
- Jeremy GebhartMeadville$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.